Clinical trials
Phase 1/2 Burkitt Lymphoma trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 3 |
| Completed | 2 |
| Recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen Research (Munich) GmbH | 1 |
| AstraZeneca | 1 |
| CRISPR Therapeutics AG | 1 |
| Celgene | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | 1 |
| Merck Sharp & Dohme LLC | 1 |
| University College, London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 8 |
| Leukemia | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Recurrence | 3 |
| Lymphoma | 2 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Anemia, Refractory | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.